AlphaMaven AlphaMaven

Moonshot targets $50B, a women's health acquisition and Clipway debuts secondaries

Reported by Axios
Jul 21, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Moonshot, a Chinese AI company behind the Kimi K3 chatbot, is in advanced fundraising discussions targeting a valuation of at least $50 billion, representing significant momentum in the generative AI sector across Asia.
  • • Meshy raised approximately $400 million in Series B funding at a $1.5 billion valuation to advance foundation models for 3D generation, attracting undisclosed institutional investors.
  • • Augustus, an NYC-based banking startup, secured $180 million in Series B funding at a $1 billion valuation, led by Tiger Global alongside Hummingbird, QED, and Brevan Howard, signaling institutional confidence in fintech infrastructure plays.
  • • Humanoid, a London-based humanoid robotics company, raised $152 million in Series A at nearly $1.4 billion valuation, with backing from Prime Movers Lab, Schaeffler, and Bosch, indicating accelerating venture investment in physical robotics.
  • • The venture capital market demonstrated broad-based activity across multiple sectors in July 2026, with cumulative funding across disclosed rounds exceeding $1.3 billion across AI, robotics, fintech, and specialized manufacturing segments.
Summary
Chinese AI company Moonshot is pursuing a fundraising round at a valuation exceeding $50 billion, according to Bloomberg reporting. The company, known for developing Kimi K3, a generative AI application, represents one of the largest valuation targets in ongoing venture discussions. The fundraising activity underscores sustained institutional appetite for advanced AI capabilities, particularly in non-U.S. markets.

Infrastructure and applied AI companies secured significant capital commitments during the period. Meshy, a Sunnyvale-based firm focused on foundation models for 3D generation, closed a Series B round of approximately $400 million at a $1.5 billion valuation from undisclosed investors. Concurrently, Gritt, an SF-based machine construction robotics company, raised $32.4 million across Series A and pre-seed rounds, backed by Obvious Ventures, Union Square Ventures, and First Round Capital.

The fintech and specialized banking sector attracted institutional capital from established alternative investment firms. Augustus, positioned as an NYC-based banking startup, raised $180 million in Series B funding at a $1 billion valuation, led by Tiger Global and joined by established venture and alternative credit platforms including Hummingbird, QED, and Brevan Howard. Venezuelan fintech company Cashea raised $100 million in combined equity and debt financing, with Spice Expeditions leading a $40 million Series A and FinSight Ventures leading a $60 million Series B, supported by $20 million in debt from Architect Capital. Additionally, Cordant, an NYC fintech and banking platform, raised $8 million in seed funding co-led by Motive Partners and Oak HC/FT.

Robotics and specialized hardware companies demonstrated strong fundraising momentum. Humanoid, a London-based humanoid robotics firm, secured $152 million in Series A funding at a nearly $1.4 billion valuation, backed by Prime Movers Lab and strategic corporate investors including Schaeffler and Bosch. TYBR Health, a Houston-based surgical technology company, raised $30 million in Series A from Vensana Capital and Mutual Capital Partners.

European companies and specialized manufacturing also participated in venture activity. Eurodia Industrie, a French liquid extraction and purification specialist, raised €18 million from Starquest Capital and Yotta Capital Partners. Mach42, a U.K.-based analog circuit simulation startup, raised £7 million led by IP Group, with participation from BGF and Foresight Group.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Axios Moonshot targets $50B, a women's health acquisition and Clipway debuts secondaries